# Glooko, Inc.

- Location (FDA's records): Palo Alto, CA
- FDA decisions: 5 (2012–2026): 5 510(k) clearances
- Product codes: NBW (3), NDC (2)
- Predicates its devices cite: 5 (2 its own); citations of its devices by later devices: 4 (2 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Bayer Healthcare, LLC: 1 (https://510kreport.com/company/bayer-healthcare)
- Voluntis Sa.: 1 (https://510kreport.com/company/voluntis)
- Monarch Medical Technologies, LLC: 1 (https://510kreport.com/company/monarch-medical-technologies)

## Firms that cite its devices most
- H2, Inc.: 1 (https://510kreport.com/company/h2)
- Welldoc, Inc.: 1 (https://510kreport.com/company/welldoc)

## Its most-cited devices
- K130886: Glooko Device System for Glooko Logbook+ Application (2013), cited by 2
- K122142: Glooko Logbook Charts (2012), cited by 1
- K171450: Glooko Mobile Insulin Dosing System (2018), cited by 1

## Recent decisions
- K260910: EndoTool IV Cloud 1.0 (May 1, 2026)
- K171450: Glooko Mobile Insulin Dosing System (Feb 2, 2018)
- K132272: Glooko Device System for Glooko Application (Oct 17, 2013)
- K130886: Glooko Device System for Glooko Logbook+ Application (Apr 25, 2013)
- K122142: Glooko Logbook Charts (Dec 21, 2012)

Source page: https://510kreport.com/company/glooko